Key result
Editorial reviews the link between hematocrit and blood pressure in primary hypertension.
Answers are grounded in this paper and cite their sources.
Editorial offers no data to guide care; leaves open hematocrit-BP link in primary hypertension for prospective study.
Editorials| December 12 2008 Relationship between Hematocrit and Blood Pressure: Implications for Primary Hypertension Subject Area: Nephrology Massimo Cirillo; Massimo Cirillo Chair of Nephrology, Department of Pediatrics, Medical School of the 'Seconda Università degli Studi di Napoli' Naples, Italy Search for other works by this author on: This Site PubMed Google Scholar Giovambattista Capasso; Giovambattista Capasso Chair of Nephrology, Department of Pediatrics, Medical School of the 'Seconda Università degli Studi di Napoli' Naples, Italy Search for other works by this author on: This Site PubMed Google Scholar Natale G. DeSanto Natale G. DeSanto Chair of Nephrology, Department of Pediatrics, Medical School of the 'Seconda Università degli Studi di Napoli' Naples, Italy Search for other works by this author on: This Site PubMed Google Scholar Nephron (1993) 65 (4): 505–510. https://doi.org/10.1159/000187555 Article history Published Online: December 12 2008 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Massimo Cirillo, Giovambattista Capasso, Natale G. DeSanto; Relationship between Hematocrit and Blood Pressure: Implications for Primary Hypertension. Nephron 1 April 1993; 65 (4): 505–510. https://doi.org/10.1159/000187555 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsNephron Search Advanced Search Article PDF first page preview Close Modal 1993Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
Círillo et al. (2008) conducted an editorial in Primary Hypertension. Hematocrit was evaluated. This publication is an editorial discussing the relationship between hematocrit and blood pressure in primary hypertension, and contains no primary clinical data.
Synapse has enriched 10 related papers. Consider them for comparative context: